PEX11A Human Pre-designed siRNA Set A contains three designed siRNAs for PEX11A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX11B Human Pre-designed siRNA Set A contains three designed siRNAs for PEX11B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX12 Human Pre-designed siRNA Set A contains three designed siRNAs for PEX12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX13 Human Pre-designed siRNA Set A contains three designed siRNAs for PEX13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX14 Human Pre-designed siRNA Set A contains three designed siRNAs for PEX14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX16 Human Pre-designed siRNA Set A contains three designed siRNAs for PEX16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX19 Human Pre-designed siRNA Set A contains three designed siRNAs for PEX19 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX2 Human Pre-designed siRNA Set A contains three designed siRNAs for PEX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX26 Human Pre-designed siRNA Set A contains three designed siRNAs for PEX26 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX3 Human Pre-designed siRNA Set A contains three designed siRNAs for PEX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX5 Human Pre-designed siRNA Set A contains three designed siRNAs for PEX5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX5L Human Pre-designed siRNA Set A contains three designed siRNAs for PEX5L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX6 Human Pre-designed siRNA Set A contains three designed siRNAs for PEX6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PEX7 Human Pre-designed siRNA Set A contains three designed siRNAs for PEX7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PF-00277343 is a selective and skin-penetrable THR-β (Ki: 0.51 nM for THR-β, 8.0 nM for THR-α) agonist. PF-00277343 is effective against androgenetic alopecia in animal models[1].

PF-03550096 is an orally active synthetic cannabinoid (CB) that selectively targets peripheral CB2 receptors with a Ki value of 7.9 nM. PF-03550096 has analgesic activity[1].

PF-04822163 is an orally active, selective, and blood-brain barrier permeable PDE1 inhibitor with IC50 values of 2 nM, 2.4 nM, and 7 nM for PDE1A, PDE1B, and PDE1C respectively. PF-04822163 can be used in the research of attention deficit hyperactivity disorder or Parkinson’s disease[1].

PF-06821497 (compound 23a) is a potent, selective and orally active Enhancer of Zeste Homolog 2 (EZH2) inhibitor, with a Ki value

PF-06821497 (compound 23a) is a potent, selective and orally active Enhancer of Zeste Homolog 2 (EZH2) inhibitor, with a Ki value

PF-06821497 (compound 23a) is a potent, selective and orally active Enhancer of Zeste Homolog 2 (EZH2) inhibitor, with a Ki value

PF-06821497 (compound 23a) is a potent, selective and orally active Enhancer of Zeste Homolog 2 (EZH2) inhibitor, with a Ki value

PF-06821497 (compound 23a) is a potent, selective and orally active Enhancer of Zeste Homolog 2 (EZH2) inhibitor, with a Ki value

PF-3635659 is a potent antagonist of the muscarinic M3 receptor (mAChR3). PF-3635659 can be used for chronic obstructive pulmonary disease (COPD) research[1].

PF-622 is a selective FAAH inhibitor, and can be used for study of analgesic and anxiolytic/antidepressant[1].

PF4 Human Pre-designed siRNA Set A contains three designed siRNAs for PF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PF4V1 Human Pre-designed siRNA Set A contains three designed siRNAs for PF4V1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFAS Human Pre-designed siRNA Set A contains three designed siRNAs for PFAS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

pFBC ([18F]pEBC) is a covalent CLIP-tag radiotracer for detection of viral reporter gene transfer in the murine brain. pFBC can be used in neurobiological research[1].

PFDN2 Human Pre-designed siRNA Set A contains three designed siRNAs for PFDN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFDN5 Human Pre-designed siRNA Set A contains three designed siRNAs for PFDN5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFDN6 Human Pre-designed siRNA Set A contains three designed siRNAs for PFDN6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PfFAS-II inhibitor 1 (Compound 3) is a Plasmodium falciparum type II fatty acid biosynthesis pathway (PfFAS-II) inhibitor, with an IC50 of 0.63 μM for PfFabI enzyme. PfFAS-II inhibitor 1 has antimalarial activity[1].

PFKFB1 Human Pre-designed siRNA Set A contains three designed siRNAs for PFKFB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFKFB2 Human Pre-designed siRNA Set A contains three designed siRNAs for PFKFB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFKFB3 Human Pre-designed siRNA Set A contains three designed siRNAs for PFKFB3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFKFB4 Human Pre-designed siRNA Set A contains three designed siRNAs for PFKFB4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFKL Human Pre-designed siRNA Set A contains three designed siRNAs for PFKL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFKM Human Pre-designed siRNA Set A contains three designed siRNAs for PFKM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFKP Human Pre-designed siRNA Set A contains three designed siRNAs for PFKP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFN1 Human Pre-designed siRNA Set A contains three designed siRNAs for PFN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFN2 Human Pre-designed siRNA Set A contains three designed siRNAs for PFN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PFN4 Human Pre-designed siRNA Set A contains three designed siRNAs for PFN4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PfPKG-IN-2 (compound 53) is a potent Plasmodium falciparum cGMP-dependent protein kinase (PfPKG) inhibitor with an IC50 value of 13 nM. PfPKG-IN-2 shows antiparasitic activity[1].

PGA3 Human Pre-designed siRNA Set A contains three designed siRNAs for PGA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.